| 0.77 Delayed Data As of Jun 14 |  -0.04 / -4.94%Today’s Change | 0.70 Today|||52-Week Range 1.90 | -49.67% Year-to-Date |
| Previous close | 0.81 |
| Today’s open | 0.77 |
| Day’s range | 0.76 - 0.77 |
| Volume | 7,249 |
| Average volume (3 months) | 6,602 |
| Market cap | $5.8M |
| Earnings growth (last year) | +77.15% |
| Earnings growth (this year) | -63.64% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +48.73% |
| P/E ratio | NM |
| Price/Sales | 0.88 |
| Price/Book | 2.11 |
| No competitors data available. |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $11.1M |
| Annual profit (last year) | -$2.1M |
| Net profit margin | -19.22% |
Sector Health Technology |
Industry Biotechnology |
Co-Chairman & Chief Executive Officer Andrey Semechkin |
Principal Financial Officer & VP-Legal Affairs Sophia Garnette |
Corporate headquarters Carlsbad, California |
